Nothing Special   »   [go: up one dir, main page]

DK3189045T3 - STILL UNKNOWN SALTS OF NILOTINIB AND ITS POLYMORPHERES - Google Patents

STILL UNKNOWN SALTS OF NILOTINIB AND ITS POLYMORPHERES Download PDF

Info

Publication number
DK3189045T3
DK3189045T3 DK15832018.4T DK15832018T DK3189045T3 DK 3189045 T3 DK3189045 T3 DK 3189045T3 DK 15832018 T DK15832018 T DK 15832018T DK 3189045 T3 DK3189045 T3 DK 3189045T3
Authority
DK
Denmark
Prior art keywords
polymorpheres
nilotinib
still unknown
salts
unknown salts
Prior art date
Application number
DK15832018.4T
Other languages
Danish (da)
Inventor
Rajamannar Thennati
Srinivasu Kilaru
Surendrakumar Macwan Valance
Dhar Dwivedi Shriprakash
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Application granted granted Critical
Publication of DK3189045T3 publication Critical patent/DK3189045T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK15832018.4T 2014-08-11 2015-08-10 STILL UNKNOWN SALTS OF NILOTINIB AND ITS POLYMORPHERES DK3189045T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2583MU2014 2014-08-11
PCT/IN2015/050086 WO2016024289A2 (en) 2014-08-11 2015-08-10 Novel salts of nilotinib and polymorphs thereof

Publications (1)

Publication Number Publication Date
DK3189045T3 true DK3189045T3 (en) 2022-03-21

Family

ID=55304722

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15832018.4T DK3189045T3 (en) 2014-08-11 2015-08-10 STILL UNKNOWN SALTS OF NILOTINIB AND ITS POLYMORPHERES

Country Status (13)

Country Link
US (1) US10138221B2 (en)
EP (1) EP3189045B1 (en)
CY (1) CY1125143T1 (en)
DK (1) DK3189045T3 (en)
ES (1) ES2908457T3 (en)
HR (1) HRP20220358T1 (en)
HU (1) HUE058726T2 (en)
LT (1) LT3189045T (en)
PL (1) PL3189045T3 (en)
PT (1) PT3189045T (en)
RS (1) RS63029B1 (en)
SI (1) SI3189045T1 (en)
WO (1) WO2016024289A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017158625A1 (en) 2016-03-17 2017-09-21 Sun Pharmaceutical Industries Ltd. Pharmaceutical composition of nilotinib
EP3404025B1 (en) * 2017-05-16 2019-12-04 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of pure nilotinib and its salt
CN112423757A (en) * 2018-06-15 2021-02-26 汉达生技医药责任有限公司 Salts of kinase inhibitors and compositions thereof
JP7422732B2 (en) * 2018-07-18 2024-01-26 アストラゼネカ・アクチエボラーグ JAK inhibitor compound xinafoate
US20230075170A1 (en) 2020-02-15 2023-03-09 Cipla Limited Novel salts of nilotinib and polymorphic forms thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03009105A (en) 2001-04-06 2004-02-12 Ciba Sc Holding Ag Sulfoxides or sulfones grafted onto polymers.
US6479692B1 (en) * 2001-05-02 2002-11-12 Nobex Corporation Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
JP2007023062A (en) 2005-07-12 2007-02-01 Jsr Corp Thermoplastic elastomer composition, method for bonding molded article thereof to molded article, composite molded article containing molded article thereof and medical infusion set having comopisite molded article
GT200600316A (en) * 2005-07-20 2007-04-02 SALTS OF 4-METHYL-N- (3- (4-METHYL-IMIDAZOL-1-ILO) -5-TRIFLUOROMETILO-PHENYL) -3- (4-PIRIDINA-3-ILO-PIRIMIDINA-2-ILOAMINO) - BENZAMIDA.
EP1923053A1 (en) 2006-09-27 2008-05-21 Novartis AG Pharmaceutical compositions comprising nilotinib or its salt
US7715251B2 (en) 2006-10-25 2010-05-11 Hewlett-Packard Development Company, L.P. Memory access strobe configuration system and process
US8350204B2 (en) 2007-12-12 2013-01-08 Mark Moser Light source tracker
JP4433093B2 (en) 2008-05-09 2010-03-17 ダイキン工業株式会社 Cross flow fan and air conditioner equipped with the same
JP2011086428A (en) 2009-10-14 2011-04-28 I-Pex Co Ltd Connector device
WO2012070062A2 (en) * 2010-11-26 2012-05-31 Hetero Research Foundation Novel polymorph of nilotinib hydrochloride
US20140059518A1 (en) 2012-08-24 2014-02-27 Velocio Networks, Inc. Method for Object Oriented Programming of Programmable Logic Controllers in Graphical Programming Languages
CN103864756B (en) * 2012-12-11 2018-06-15 四川海思科制药有限公司 Fourth disulfonic acid dabigatran etcxilate and its preparation method and application
CN104644543A (en) * 2014-12-25 2015-05-27 青岛黄海制药有限责任公司 Dabigatran-containing solid dispersion and preparation method as well as application thereof

Also Published As

Publication number Publication date
LT3189045T (en) 2022-04-11
ES2908457T3 (en) 2022-04-29
PL3189045T3 (en) 2022-04-04
US10138221B2 (en) 2018-11-27
US20170233372A1 (en) 2017-08-17
RS63029B1 (en) 2022-04-29
EP3189045A4 (en) 2018-02-14
EP3189045A2 (en) 2017-07-12
HUE058726T2 (en) 2022-09-28
SI3189045T1 (en) 2022-05-31
WO2016024289A3 (en) 2016-09-15
CY1125143T1 (en) 2023-06-09
PT3189045T (en) 2022-03-17
HRP20220358T1 (en) 2022-05-13
EP3189045B1 (en) 2022-02-09
WO2016024289A2 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
DK3102576T3 (en) DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA
DK3851537T3 (en) TREATMENT OF HYPERBILIRUBINAMIA
DK3137169T3 (en) INHIBITORIES OF LYSIN-SPECIFIC DEMETHYLASE-1
DK3215147T3 (en) NEUROTENANT NORKETAMINE COMPOUNDS AND METHODS
DK3160956T3 (en) Inhibitors of lysine-specific demethylase-1
DK3521289T3 (en) MNK INHIBITORS AND METHODS RELATED THEREOF
DK3164380T3 (en) INHIBITORS OF LIGHT-SPECIFIC DEMETHYLASE-1
DK3102673T3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-TALASSEMI
DK3123260T3 (en) SELECTIVE PROCESSING OF SENSOR DATA
DK3185868T3 (en) Novel ULK1 inhibitors and methods of using the same
DK3119772T3 (en) HETEROARYL SICK INHIBITORS
MA40933A (en) DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES
DK3144001T3 (en) Compositions of selenoorganic compounds and methods of their use
DK3429998T3 (en) Process for the preparation of quinolin-2-yl-phenylamine derivatives and their salts
DK3215493T3 (en) SYNTHESIS OF COPANLISIB AND DIHYDROCHLORIDE SALT
DK3186242T3 (en) ALFA-AMINO-BETA-CARBOXYMUCONSIDE-SEMIALDEHYDE-DECARBOXYLASE INHIBITORS
DK3161139T3 (en) TLR-4-SPECIFIC APPROACHES AND USES THEREOF
DK3132009T3 (en) COURSE OF ACTION
DK3365323T3 (en) Salts of tetracyclines
DK3307267T3 (en) TREATMENT OF MULTIPLE SHELLOSIS
DK3283210T3 (en) COURSE OF ACTION
DK3094322T3 (en) ADMINISTRATION OF TASIMELTEON IN FIXED MODE
DK3233105T3 (en) Hitherto UNKNOWN COMBINATION AND USE
DK3164123T3 (en) Novel uses of benzylideneguanidine derivatives in the treatment of proteopathies
DK3204352T3 (en) Inhibitors of lysine-gingipain